Clinical trial
Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
NCT02822989 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
- Lead sponsor
- Northwell Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2017
- Completion date
- November 1, 2020
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.